SCHEMBL19685903

SCHEMBL19685903

Cc1coc2cc(-n3c4ccccc4c4cc(-n5c6ccccc6c6ccccc65)ccc43)ccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.40
ALDH1A1 P00352 6/20 0.40
HPGD P15428 4/20 0.40
HSD17B10 Q99714 3/20 0.40
USP2 O75604 2/20 0.40
PDE10A Q9Y233 1/20 0.37
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOB P27338 5/20 0.35
TOP2A P11388 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
CYP3A4 P08684 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685688 0.91 PDE10A (0.38) KDM4EALDH1A1PDE10AATML3MBTL1
SCHEMBL19685895 0.86 PTPN1 (0.47) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL19685893 0.83 ALDH1A1 (0.36) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL19685850 0.82 KDM4E (0.38) KDM4EALDH1A1HSD17B10USP2ATM
SCHEMBL19685804 0.82 KDM4E (0.38) KDM4EALDH1A1HSD17B10USP2ATM
SCHEMBL19685689 0.79 PTPN1 (0.50) ALDH1A1PDE10AMAOBTOP2ARAB9A
SCHEMBL17752235 0.79 MAOA (0.51) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL22146535 0.79 MAOA (0.51) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL29531498 0.79 MAOA (0.51) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL30646338 0.79 MAOA (0.51) KDM4EALDH1A1HPGDHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS KDM4E 1138/4885ALDH1A1 572/4885HPGD 901/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS KDM4E 1138/4885ALDH1A1 572/4885HPGD 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.